Company
Every investor coverage indicates participated in a round Cogstate raised.
Companies Cogstate acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Cogstate. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
GBS Ventures announces it has fully wound down its 1998 biotech fund with returns in the top quartile of US peers, recalling portfolio listings, Dynamic Hearing's sale to Wolfson, and its $122.5m fourth fund.
CogState has signed agreements giving it up to A$1.28 million in non-dilutive funding from Pfizer over three years for paediatric cognitive tests, speech-analysis technology and dementia detection tools, with work undertaken in Australia.